INTRODUCTION
The steady-state level of mRNA accumulation is determined from the rate of its biosynthesis and degradation. Stability of mRNA can be regulated as a physiological response within the cell [1] [2] [3] and also by external stimuli, such as Ca# + , hormone, cytokine, virus and inflammatory mediators [4] [5] [6] [7] [8] [9] [10] [11] . Although mechanisms involved in post-transcriptional mRNA regulation are complex, the mRNA itself contains sequence-specific information which determines its stability [reviews, [12] [13] [14] . A group of unstable mRNAs with a half-life (t "/# ) of approx. 15-60 min, which include mRNAs of oncogenes and cytokines, carries AU-rich domains (ARDs) in their 3h-untranslated region (UTR) [12] [13] [14] . Single or multiple copies of ARD function as the mRNA-destabilizing element, as shown by in i o and in itro experiments using deletion and mutation analysis of the RNA, as well as by utilizing chimaeric gene constructs [15] [16] [17] [18] .
We have previously shown that infection of primary astrocytes by Newcastle disease virus (NDV) induces tumour necrosis factor α (TNFα) gene transcription and stabilization of TNFα mRNA with prolonged t "/# [8, 19] . Whereas protein kinase C (PKC) inhibitors partially inhibit TNFα gene transcription, the mRNA stabilization mediated by NDV is effectively abolished by various PKC inhibitors in astrocytes [8, [19] [20] [21] . Kinasedependent stability of TNFα mRNA was also shown in human monocytes where treatment with okadaic acid to inhibit protein phosphatases led to TNFα mRNA stabilization [22] . We have also demonstrated that the regulated step in PKC-dependent Abbreviations used : ARD, AU-rich domain ; DTT, dithiothreitol ; EMSA, electrophoretic mobility-shift assay ; FCS, fetal calf serum ; IL, interleukin ; NDV, Newcastle disease virus ; PKC, protein kinase C ; PP, protein phosphatase ; PTP, protein tyrosine phosphatase ; TNFα, tumour necrosis factor α ; UTR, untranslated region ; DMEM, Dulbecco's modified Eagle's medium ; moi, multiplicity of infection.
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band or doublets. The UV cross-linked ARD-protein complexes, however, migrated as a single 35 kDa band on SDS\PAGE. In cytoplasmic extracts treated with alkaline phosphatase there was a decrease in the faster moving complex and an increase in the slower moving complex, whereas NDV infection produced the reverse effect. In addition, the faster moving complex was decreased when cytoplasmic extracts from NDV-infected cells were treated with protein phosphatase 1 or 2A. Neither NDV infection nor phosphatase treatment affected the mobility pattern of nuclear extracts. The data indicate that a protein of molecular mass less than 35 kDa binds to a segment of TNFα ARD containing primarily UUAUUUAUU motifs, and the ARDbinding activity in cytoplasmic compartment is posttranscriptionally modified.
TNFα mRNA stabilization involves deadenylation of the poly(A) tail [21] . The poly(A) tail is protected from deadenylation by poly(A)-binding protein, and poly(A) shortening is believed to be required for endo-or exo-nucleases to attack the mRNA for degradation [23] [24] [25] [26] . Poly(A) deadenylation and mRNA degradation can be regulated by sequence-specific elements within ARD [27, 28] , and the nonamer UUAUUUAUU appears to be the key AU-rich sequence motif that mediates mRNA degradation [29] . ARD-binding proteins of molecular mass between 16 and 65 kDa have been identified that can bind to a variety of AU-rich elements present in unstable mRNAs, such as those encoding interferon β, TNFα, interleukin (IL)-2, c-Fos, c-Jun, c-Myc and granulocyte-macrophage colony-stimulating factor [9, [30] [31] [32] [33] [34] [35] [36] . In addition to the ARD in regions of untranslated mRNA, ARD located within the coding sequences also serves as a binding site for the ARD-binding proteins and functions as an instability element [9] . At present, it is unknown whether kinase-dependent stabilization of unstable mRNAs, such as that described for TNFα, occurs through a modification of proteins that bind to the ARD.
In the present study, we analysed protein binding to TNFα 3h-UTR in primary rat astrocytes. We identified a protein of approx. 35 kDa that binds to a 27 nt segment within 3h-UTR ARD. On electrophoretic mobility shift assay (EMSA), the ARD-protein complexes migrated as two bands, in which the slower moving complexes were noted as a broader band or a doublet. This mobility pattern was altered when cells were infected with NDV and when cytoplasmic extracts were treated with phosphatases.
MATERIALS AND METHODS

Primary cultures of rat astrocytes and treatment with NDV
Astrocytes were purified from stratified cultures of mixed glial cells from neonatal Sprague-Dawley rat brains using the method of McCarthy and DeVellis with modification as described [37, 38] . More than 95 % of cells at the final step of isolation expressed glial fibrillary acidic protein, an astrocyte marker, and less than 2 % were positive for CD11b, the iC3b receptor expressed on microglia but not on astrocytes [21, 39] . Astrocyte monolayers were grown in 75 cm# flasks (Corning, Corning, NY, U.S.A.) in Dulbecco's modified Eagle's medium (DMEM)\Ham's F12 containing 10 % fetal calf serum (DMEM\FCS). The New Jersey La Sota strain of NDV (ATCC, Rockville, MD, U.S.A.) was grown in fertilized chicken eggs and the viral titres were determined as described [38] . The stock suspension was diluted with DMEM before each experiment. Astrocytes preincubated in serum-free DMEM for 3 h were infected with NDV at a multiplicity of infection (moi) of 30, also in serum-free DMEM [38] .
Chemicals and reagents
A protein kinase inhibitor H-7 [40] was purchased from Seikagaku America CO. 
Northern-blot analysis of TNFα mRNA
The effect of kinase inhibitor, H-7, on NDV-induced TNFα mRNA stability was determined as previously reported [8] . In brief, cells kept in serum-free medium for 30 min were infected with 30 moi of NDV for 2 h in DMEM, and then an equal volume of DMEM\FCS was added for an additional 4 h of incubation. An RNA polymerase II inhibitor α-amanitin (5 µg\ml) was then added to the culture with or without 60 µM H-7 and cells were further incubated. At different time points after α-amanitin addition, total RNA was extracted and the relative levels of TNFα mRNA were determined by Northernblot analysis [8] . A 1n1 kb EcoRI-PstI fragment of murine TNFα cDNA (kindly provided by Dr. B. Beutler, University of Texas, Dallas, TX, U.S.A.) and 1n4 kb HindIII fragment of β-actin cDNA were used to probe the mRNA.
Preparation of nuclear and cytosolic extracts
Astrocytes were collected by scraping and centrifuged at 600 g (2000 rev.\min) for 10 min at 4 mC. Cytoplasmic and nuclear extracts were prepared as described previously [41] . In brief, cell pellets (1i10() were suspended in 0n2 ml of lysis buffer [10 mM Hepes, pH 7n6, 3 mM MgCl # , 40 mM KCl, 2 mM dithiothreitol (DTT), 5 % glycerol, 0n5 % Nonidet P40, 8 µg\ml leupeptin and 0n5 mM PMSF] and the suspension was kept on ice for 15 min. Nuclei were pelleted at 3000 g (12 000 rev.\min) for 10 min at 4 mC in a Beckman Microfuge and the supernatants were used as cytoplasmic extracts. To obtain nuclear extracts, the pelleted nuclei were washed in wash buffer (10 mM Hepes, pH 7n6, 1n5 mM MgCl # , 10 mM KCl, 0n5 mM PMSF and 1 mM DTT) and then suspended in extraction buffer (20 mM Hepes, pH 7n6, 0n42 M NaCl, 25 % glycerol, 1n5 mM MgCl # , 0n2 mM EDTA, 0n5 mM PMSF and 1 mM DTT). The mixtures were stirred for 30 min at 4 mC, then centrifuged at 3000 g for 10 min at 4 mC. The supernatants were dialysed against extraction buffer containing 0n1 M KCl instead of 0n42 M NaCl. Protein concentration was determined by BCA protein assay (Pierce Chemical Co., Rockford, IL, U.S.A.). Samples were stored at k70 mC and used within 10 days.
Construction of plasmids and preparation of RNA probes
Plasmids containing the ARD of TNFα 3h-UTR were prepared by inserting double-stranded oligonucleotides, 5h-GAGTG TCGAC ATTTA TATTT GCACT TATTA TTTAT TATTT ATTTA TTATT TATTT ATTTG CTTAT GAATG TATTT ATCTA GAGAG T-3h, into the XbaI-Sal I site of the polylinker region of pGEM4 plasmid (Promega, Madison, WI, U.S.A.). Oligonucleotides were prepared with the Sal I-XbaI-and EcoRI-Sal I-recognition sequences at the 5h and 3h end respectively. Bgl II and SspI segment (296 bp) of mouse TNFα cDNA 3h-UTR containing ARD was also inserted into the polylinker region of pGEM4. Plasmids containing an IL-6 ARD were prepared by inserting a sequence, 5h-ATTTA TTGAT AATTT AAATA AGTAA ACTAT AAGTT AATTT ATGAT TGATA TTTA-3h, into pGEM3. Plasmids linearized with XbaI or Sal I were used as templates for RNA synthesis using the Trans Probe Kits from Pharmacia (Piscataway, NJ, U.S.A.) as described by the manufacturer. RNA was purified by a series of phenol, chloroform and ethanol precipitations or by low-meltingpoint agarose-gel electrophoresis, followed by phenol, chloroform and ethanol precipitation. RNA transcripts were labelled with [α-$#P]UTP (800 Ci\mmol) to yield a specific radioactivity of approx. 3i10) c.p.m.\µg of RNA.
Analysis of RNA-protein complex by EMSA and SDS/PAGE
Cytoplasmic or nuclear extracts (10 µg of protein) were incubated at room temperature for 20 min with labelled RNA probes (4 ng) in a binding buffer (10 mM Hepes, pH 7n6, 40 mM KCl, 3 mM MgCl # , 2 mM DTT, 5 % glycerol and 0n5 % Nonidet P40). The mixtures were further incubated for 10 min with heparin (30 µg\ml) and yeast RNA (50 µg\ml), in a final volume of 15 µl. RNA not associated with proteins was digested with RNase T1 (30 units) (Boehringer-Mannheim, Indianapolis, IN, U.S.A.) for 20 min at room temperature. The RNase-resistant complexes were resolved by non-denaturing PAGE (6 % gel) in 0n4i Tris\borate\EDTA buffer at a constant voltage of 250 V. To cross-link proteins to RNA, RNA\protein mixtures were transferred to a 96-well plate and the samples were irradiated at 254 nm UV (250 mJ) in a Stratalinker UV apparatus. The samples were digested with RNase T1, then with 1 mg\ml RNase A for 15 min at 37 mC, and were analysed by SDS\PAGE (10 % gel) under reducing conditions. In some experiments RNA probes and proteins were allowed to bind in cytoplasmic or nuclear extracts, and digested with RNases as described. The RNaseresistant complexes were resolved in low-melting-point agarose gel, UV-cross-linked in situ. The protein-RNA bands identified by autoradiography were excised, resuspended in Laemmli buffer and analysed by SDS\PAGE (10 % gel) under reducing conditions. The binding specificity was determined by incubating the extracts with unlabelled competitor RNA for 10 min at room temperature in binding buffer before adding the labelled probe. Competitor RNA included poly(A), poly(U), poly(G), poly(C) ribopolymers (Sigma), a 66 nt ARD segment homologous to the probe, and three smaller segments derived from the 66 nt ARD probe. Protein binding to an AU-rich domain of tumour necrosis factor α mRNA
Effects of phosphatases and NDV
In order to assess directly the effect of phosphorylation on ARDprotein complex-formation, cytoplasmic and nuclear extracts were incubated with acid phosphatase (10 mg\ml), alkaline phosphatase [agarose-bound enzyme was used according to the manufacturer's (Sigma) instructions] for 30 min in binding buffer before the addition of the labelled probe and analysed by EMSA. In addition, to determine whether the ARD-binding properties induced by NDV are affected post-transcriptionally, cytoplasmic and nuclear fractions of astrocytes infected with NDV in the presence or absence of 60 µM H-7 were examined by EMSA. The NDV-stimulated nuclear and cytoplasmic extracts were also treated with PP-1 (0n2 unit), PP-2A (0n2 unit), PP-2B (250 ng) or PTP-1B (10 µl of PTP-1B-agarose) for 30 min before the addition of the labelled probe.
RESULTS
TNFα mRNA stability analysed by Northern blotting
Astrocytes were stimulated with NDV to induce expression of the TNFα gene. Transcription was blocked by α-amanitin, and cells were incubated in the presence or absence of H-7 (60 µM), then the levels of TNFα mRNA were determined by Northern blot. In the presence of H-7, TNFα was rapidly degraded to undetectable level by 3 h, whereas the mRNA decay was much slower in the absence of H-7 ( Figure 1 ).
Identification of specific RNA-binding protein to TNFα mRNA
The 3h-UTR of TNFα mRNA spans nts j1203 to j1626 and the ARD spans nts j1292 to j1357, as shown in Figure 2 . These sequences were used as probes and inhibitors in binding assays for EMSA. The ARD probe consists of 65 nts containing seven AUUUA motifs and Sal I and XbaI sites at the 5h and 3h border respectively. This ARD region was further divided into three segments and these smaller segments were used as probes or inhibitors for the RNA-protein complex-formation ( Figure  2 ). Both nuclear and cytoplasmic fractions formed RNase T1-resistant complexes with the 3h-UTR probe (Figure 3, left) . When ARD was used as a probe, two complexes were resolved in unstimulated cells, a faster complex as a narrow band and a slower and broader complex (Figure 3, centre) . Both methods used for preparing the RNA probe produced a similar RNAprotein-binding pattern. The 74 nt ARD in IL-6 3h-UTR used for comparison showed that this IL-6 probe also formed RNA-
Figure 1 Effects of kinase inhibitor H-7 on NDV-induced TNFα mRNA decay
Primary rat astrocytes were infected with 30 moi of NDV for 6 h. Cells were further incubated with 5 µg/ml α-amanitin and with (j) or without (k) 60 µM H-7 for the indicated time periods. Relative TNFα mRNA expression was determined by Northern-blot analysis using 10 µg of total RNA per lane. Unstimulated and stimulated astrocytes with NDV for 6 h are also shown. β-Actin mRNA, used as a control, was not affected by virus or kinase inhibitors in this experiment.
Figure 2 Probes used in the binding experiments
Probes used in the binding experiments are shown. A probe within 3h-UTR of TNFα is composed of 425 nts spanning j1203 to j1626. ARD is composed of nts j1292 to j1357. Three smaller probes derived from the ARD are shown. Probes 1 and 3 are underlined and probe 2 is double underlined.
Figure 3 RNA EMSA using astrocyte extracts and TNFα 3h-UTR, TNFα ARD and IL-6 ARD
Radiolabelled in vitro -synthesized RNA representing TNFα 3h-UTR, TNFα ARD (TNF AU-rich) or IL-6 ARD (IL6 AU-rich) was incubated with nuclear (N) or cytosolic (C) extracts (10 µg of protein), as described in the Materials and methods section. Reaction mixtures were digested with RNase T1, and electrophoresed on 6 % polyacrylamide gel under non-denaturing conditions. Binding to 32 P-labelled TNFα ARD (j1292/j1357) generated two complexes. Binding to TNFα 3h-UTR (j1203/j1626), IL-6 ARD (j841/j896) and probe alone (P) is also shown.
binding complexes with astrocyte nuclear and cytoplasmic extracts ; however, the mobilities of these protein complexes significantly differed from those of the TNFα ARD-protein complexes (Figure 3, right) .
The binding specificity for TNFα ARD probe was studied by inhibition of complex-formation with unlabelled ribopolymers. Preincubation of the extracts with 250 ng (about 60-fold excess) of poly(A) and poly(U) showed that the binding was inhibited
Figure 4 Inhibition of ARD binding in nuclear and cytosolic extracts by poly( U )
Nuclear (N) and cytoplasmic (C) extracts were pretreated with 250 ng of unlabelled ribohomopolymers before incubation with 4 ng of labelled TNFα ARD probe. Extracts not treated with inhibitors (none) and probe alone (P) are also included.
Figure 5 Identification of the complex-forming sites in TNFα ARD
RNA-binding assays and EMSA were carried out with cytosolic extracts (10 µg) and 4 ng of 32 P-labelled ARD (T) or probes 1-3 (see Figure 2) . In a competition assay, ARD (T) was used as a probe and unlabelled ARD fragments 1, 2 and 3 as competitors. Experiments with nuclear extracts gave similar results (not shown).
only with poly(U) (Figure 4 ). Even at 1 µg, poly(A), poly(C) and poly(G) failed to inhibit ARD-protein complex-formation (results not shown). The binding specificity was shown by almost complete inhibition of the binding with 20 molar excess of
Figure 6 Detection of ARD-binding proteins by UV cross-linking and SDS/PAGE
The ARD-protein complexes were cross-linked by UV irradiation (j), then digested with RNase T1 or RNase T1 followed by RNase A. Samples, including probe alone (P) and extracts incubated with probes, but not UV-cross-linked (k), were analysed by SDS/PAGE (10 % gel). RNase T1 treatment generated a 45 kDa RNA-protein complex. Additional treatment using RNase A reduced the complex to a 35 kDa band.
unlabelled homologous ARD ( Figure 5 ). The specific binding site within ARD was then examined with three smaller oligonucleotides derived from ARD (see Figure 2 ) used as probes (probe 1, 2 and 3) or competitors at 20 molar excess ( Figure 5 ). Whereas probe 1 and probe 3 each containing a single AUUUA motif failed to produce complex-formation with cytoplasmic extracts, probe 2 generated two well-defined bands. Probe 2 which contained five overlapping AUUUA motifs, three of them as a UUAUUUAUU nonamer, was able to form RNase-resistant complexes. Identical experiments with nuclear extracts produced similar results (not shown).
Identification of ARD-binding proteins by UV cross-linking
When nuclear or cytoplasmic extracts were treated with proteinase K, complex-formation with ARD was completely abolished (results not shown). To characterize the ARD-binding proteins, the RNA-protein complexes were UV-cross-linked and the ARD-protein adducts were analysed by SDS\PAGE (10 % gel). UV-cross-linked RNase-T1-resistant ARD-protein complexes present in nuclear and cytoplasmic extracts migrated as a single band with a molecular mass of 45 kDa (Figure 6 ). Further digestion with RNase A reduced the mass of the complex to 35 kDa. Similar results were obtained by cross-linking the complexes in an agarose gel (not shown). Extracts from NDVstimulated astrocytes produced an identical size complex (results not shown).
Effects of phosphatase treatment of cytosolic extracts on formation of ARD-protein complexes
To determine whether ARD-protein complex-formation is affected by the state of phosphorylation of the ARD-binding protein, cytoplasmic and nuclear extracts were treated with phosphatases, then the mobility pattern of ARD-protein complexes was examined. Alkaline phosphatase completely abolished the formation of the faster moving complex with cytoplasmic extracts, whereas the effect of acid phosphatase was minimal 
Figure 8 Effects of phosphatases on NDV-induced ARD-protein complexes
Top, Astrocytes infected with NDV for 0n5, 1, 2 and 3 h in the absence or presence of H-7. Cytoplasmic extracts were then examined for the mobility pattern of the ARD-protein complexes. Bottom, Nuclear and cytoplasmic extracts from astrocytes infected with NDV for 1 and 3 h were treated with PP-1, PP-2A or PP-2B for 30 min before ARD binding and EMSA.
( Figure 7 ). Complex-formation with nuclear extracts was minimally affected by alkaline phosphatase. Cytoplasmic extracts from NDV-infected astrocytes produced an increase in the faster moving complex at 1 h after infection and this effect was significantly reduced when cells were infected with NDV in the presence of H-7 (Figure 8, top) . Treatment of NDV-stimulated cytoplasmic but not nuclear extracts with PP-1 or PP-2A also reduced faster migrating complex (Figure 8, bottom) . Treatment with PP-2B and PTP-1B (not shown) was not effective. PP-1 and PP-2A are highly specific phosphatases for serine and threonine residues, whereas PP-2B [42] and PTP-1B [43] dephosphorylate tyrosine residues.
DISCUSSION
This work is the first to explore systematically protein binding to the 3h-UTR region of TNFα. We have shown that the nuclear and cytoplasmic extracts from serum or NDV-stimulated astrocytes contain proteins that bind to an ARD of TNFα 3h-UTR and that these ARD-protein complexes migrate as two bands in EMSA. By UV cross-linking and SDS\PAGE, we have identified a 35 kDa ARD-protein complex after extensive RNase treatment. Thus the molecular mass of the TNFα ARD-binding protein would be less than 35 kDa, because some RNA is still covalently linked. The competition assays have shown that the binding to ARD was uridine-specific and was restricted to a centrally located segment of the ARD, which contains five overlapping AUUUA motifs, primarily as a UUAUUUAUU nonamer motif. A single AUUUA motif within ARD did not show ARD-binding activity, when examined directly by using these sequences as targets or indirectly as inhibitors. The results are consistent with a recent report that demonstrates UUAUUUAUU as the key AU-rich sequence motif that mediates poly(A) deadenylation in mRNA decay [29] .
Previously, a number of ARD-binding proteins have been identified [9, [30] [31] [32] [33] [34] [35] [36] 44] . The molecular mass of these ranged between 30 and 45 kDa, except the 59 and 65 kDa [9, 45] proteins that bind the c-Myc and interferon β ARDs respectively. Brewer's group demonstrated that a 37 and 40 kDa protein binding to cMyc and granulocyte-macrophage colony stimulating factor 3h-UTR are both phosphoproteins and immunologically crossreactive [36, 45] . The deduced sequence of the cloned 37 kDa protein showed two RNA-recognition motifs and possible domains of protein-protein interaction [36] . Whether TNFα ARDbinding protein is related to the other ARD-binding protein is unknown at present. It is also interesting to note that a 35 kDa ARD-binding protein is induced on stimulation by β-adrenergic receptor agonist, and induction of this complex destabilizes β-adrenergic receptor transcript, an otherwise stable mRNA [46, 47] .
The effects of NDV and phosphatases on the mobility of ARD-protein complexes were examined because TNFα mRNA induced by NDV is stabilized through a PKC-dependent pathway [8, 21] . Formation of faster moving complex was increased in astrocytes by NDV, but this complex-formation was significantly reduced by H-7, a kinase inhibitor, and also when NDVstimulated cytoplasmic extracts were treated with serine and threonine phosphatases. These data indicate that the ARDbinding protein can be post-transcriptionally modified in a kinase-dependent manner only in the cytoplasmic compartment. Although the effect of protein phosphorylation on mRNA stability is not yet known, it is possible that phosphorylation of ARD-binding protein may affect the affinity of ARD binding and\or interaction of ARD-binding protein with other proteins such as poly(A)-binding protein and endo-and exo-nucleases. This speculation is consistent with our finding that PKC activity is required to prevent poly(A) tail degradation to achieve TNFα mRNA stability [21] .
Stabilization of TNFα mRNA in astrocytes may be biologically significant, since TNFα, which is increased in the spinal fluid of multiple sclerosis patients, is predominantly localized in astrocytes within actively demyelinating lesions [48] [49] [50] . In addition, the requirement of TNFα in immune-mediated demyelination has been shown in animal models [51, 52] . Thus sustained production of TNFα by glial cells after virus infection through the mechanism of mRNA stabilization can be a significant factor during the course of inflammatory diseases affecting the central nervous system. This work is supported in part by US Public Health grants RO-1-NS 15662 and NS 20022. We greatly appreciate the excellent contribution of Dr. M. Chi in preparing primary cultures of astrocytes and Mrs. Nayereh Dehghan for typing this manuscript.
